Brief: Theratechnologies Submits Supplemental Biologics License Application To FDA Advancing Development Of Iv Push Trogarzo® For Patients Living With Hiv

Theratechnologies

06/12/2021 16:54

Theratechnologies Inc  TH.TO :
    * THERATECHNOLOGIES SUBMITS SUPPLEMENTAL BIOLOGICS LICENSE
APPLICATION TO FDA ADVANCING DEVELOPMENT OF IV PUSH TROGARZO®
FOR PATIENTS LIVING WITH HIV
    * THERATECHNOLOGIES INC - TMB-302 SHOWED NO SERIOUS ADVERSE
EVENTS
AND DRUG-RELATED ADVERSE EVENTS WERE CONSIDERED MILD TO MODERATE

Source text for Eikon:  ID:nGNX8pJ4kH 
Further company coverage:  TH.TO